We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+2.54%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.67B
AUM Growth
-$84.4M
Cap. Flow
-$71.4M
Cap. Flow %
-4.28%
Top 10 Hldgs %
27.6%
Holding
266
New
9
Increased
45
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
YOU icon
Clear Secure
YOU
+$16.3M
2
FN icon
Fabrinet
FN
+$13.4M
3
GENI icon
Genius Sports
GENI
+$5.41M
4
WEX icon
WEX
WEX
+$4.07M
5
VRNA
Verona Pharma
VRNA
+$3.85M

Sector Composition

Rank Sector Weight
1 Healthcare 31.45%
2 Technology 26.46%
3 Industrials 18%
4 Consumer Staples 6.55%
5 Communication Services 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICR icon
201
Vicor
VICR
$10.2B
$1.15M 0.07%
34,562
-370
-1% -$12.8K
VMC icon
202
Vulcan Materials
VMC
$36.9B
$1.14M 0.07%
4,585
-63
-1% -$16.3K
BRK.B icon
203
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.14M 0.07%
2,800
AAOI icon
204
Applied Optoelectronics
AAOI
$11.5B
$1.11M 0.07%
134,123
-6,565
-5% -$72.2K
DOV icon
205
Dover
DOV
$28.4B
$1.09M 0.07%
6,015
-67
-1% -$12K
YMAB
206
DELISTED
Y-mAbs Therapeutics
YMAB
$1.08M 0.07%
89,735
+3,589
+4% +$48.5K
CW icon
207
Curtiss-Wright
CW
$25.5B
$1.08M 0.06%
3,985
-369
-8% -$98.6K
OPTN
208
DELISTED
OptiNose
OPTN
$1.03M 0.06%
65,879
-339
-0.5% -$5.68K
TBRG
209
DELISTED
TruBridge
TBRG
$834K 0.05%
83,367
+3,031
+4% +$27.6K
ABBV icon
210
AbbVie
ABBV
$435B
$811K 0.05%
4,727
ASUR icon
211
Asure Software
ASUR
$250M
$782K 0.05%
+93,148
New +$704K
TECH icon
212
Bio-Techne
TECH
$11.3B
$734K 0.04%
10,238
-61
-0.6% -$4.49K
CR icon
213
Crane Co
CR
$12.7B
$714K 0.04%
4,927
-65
-1% -$9.21K
IEX icon
214
IDEX
IEX
$17.3B
$693K 0.04%
3,443
-26
-0.7% -$5.68K
KEX icon
215
Kirby Corp
KEX
$6.93B
$691K 0.04%
5,770
-80
-1% -$8.94K
UPLD icon
216
Upland Software
UPLD
$15.4M
$681K 0.04%
27,358
+976
+4% +$25.7K
CDW icon
217
CDW
CDW
$17B
$675K 0.04%
3,016
-41
-1% -$9.51K
BRKR icon
218
Bruker
BRKR
$8.14B
$668K 0.04%
10,470
-95
-0.9% -$7.15K
TDY icon
219
Teledyne Technologies
TDY
$32B
$646K 0.04%
1,664
+7
+0.4% +$2.77K
TVTX icon
220
Travere Therapeutics
TVTX
$5.78B
$626K 0.04%
76,174
+2,774
+4% +$18.7K
EW icon
221
Edwards Lifesciences
EW
$51.7B
$619K 0.04%
6,705
-113
-2% -$10K
BRK.A icon
222
Berkshire Hathaway Class A
BRK.A
$1.12T
$612K 0.04%
1
CVX icon
223
Chevron
CVX
$366B
$585K 0.04%
3,737
FWRG icon
224
First Watch Restaurant Group
FWRG
$766M
$584K 0.04%
+33,253
New +$695K
ARAY icon
225
Accuray
ARAY
$34M
$565K 0.03%
310,252
-260,081
-46% -$496K

Similar funds

Rice Hall James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Rice Hall James & Associates held 266 positions worth $1.67B, down 4.8% from $1.75B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rice Hall James & Associates withdrew a net $71.4M in Q2 2024, closing 10 positions and reducing 189 holdings. Its most notable exit was MASONITE INTERNATIONAL CORP, an estimated $51.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Genius Sports worth $5.52M.

  • Rice Hall James & Associates's largest Q2 2024 buy was Genius Sports: 1,012,949 shares worth $5.52M.
  • Rice Hall James & Associates added most to Clear Secure in Q2 2024, an estimated $16.3M increase.
  • Rice Hall James & Associates's biggest Q2 2024 reduction was Stride, cutting an estimated $4.13M.
  • Rice Hall James & Associates fully exited MASONITE INTERNATIONAL CORP in Q2 2024, selling an estimated $51.9M.
  • Rice Hall James & Associates's ten largest holdings make up 28% of its $1.67B portfolio in Q2 2024.
  • Rice Hall James & Associates opened 9 new positions and closed 10 in Q2 2024.
  • Rice Hall James & Associates's portfolio value fell 4.8% quarter-over-quarter to $1.67B.

Based on Rice Hall James & Associates's 13F filing for Q2 2024, filed 7 Aug 2024.